- Degos, L., Dombret, H., Chomienne, C., Daniel, M.-T., Miclea, J.-M., Chastang, C., Castaigne, S. and Fenaux, P. (1995) "All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia", Blood 85, 2643-2653.
- Vendilli, A., Stasi, R., del Poeta, G., Buccusano, F., Aronica, G., Bruno, A., Pisani, F. Caravita, T., Masi, M., Tribalto, M., Domenica Simone, M., Avvisati, G., Amadori, S. and Papa, G. (1995) "Alltrans retinoic acid and low-dose cytosine arabinoside for the treatment of poor-prognosis acute myelogenous leukemia", Leukemia 9, 1121-1125.
- Kramer, Z.B., Boros, L., Wiernik, P.H., Anderson, J., Bennett, J.M., Cassileth, P. and Oken, M. (1991) "13-cis-retinoic acid in the treatment of elderly patients with acute leukemia", Cancer 67, 1484-1486.
- Estey, E.H., Thall, P.F., Pierce, S., Cortes, J., Beran, M., Kantarjian, H., Keating, M.J., Andreeff, M. and Freireich, E. (1999) "Randomized phase II study of fludarabine + cytosine arahinoside + idarubicin +/- all-trans retinoic acid +/ granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome", Blaod 93, 2478-2484.
- Tallman, M. (1996) "Differentiation therapy in acute myeloid leukemia", Leukemia 10, 1262-1268.
- Cheson, B.D., Jasperse, D.M., Simon, R. and Friedman, M.A. (1986) "A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes", J. Clin. Oncol. 4, 1857-1864.
- Hassan, H.T. and Rees, J.K.H. (1998) "Retinoic acid alone and in combination with cytosine arabinoside induces differentiation of human myelomonocytic and monoblastic leukaemic cells", Hamatol. Oncol 6, 39-45.
- Cortesi, R., Gui, V., Osti, F., Nastruzzi, C. and Garapari, R. (1998) "Human leukemic K562 cells treated with cytosine arabinoside: enhancement of erythroid differentiation by retinoic acid and retinol", Eur. J. Haematol 61, 295-301.
- Lishner, M., Curtis, J.E. Minkin, S. and McCulloch, E.A. (1989) "Interaction between retinoic acid and cytosine arabinoside affecting the blast cells of acute mycloblastic leukemia", Leukemia 3, 784-788.
- Jantunen, E., Mahlamäki, E. and Nousiainen, T. (1998) "Low-dose cytarabine plus all-trans retinoic acid in myelodysplastic syndromes and poor-risk acute myelogenous leukemia", Br. J. Haematol. 102, 222, Abstract.
- Parrado, A., Chomienne, C. and Padua, R.A. (2000) "Retinoic acid receptor alpha (RARalpha) mutations in human leukemia", Leuk. Lymhoma 39, 271-282.
- Dash, A. and Gilliland, D.G. (2001) "Molecular genetics of acute myeloid leukaemia", Best Pract Res. Clin. Haematol. 14, 49-64.
- Braess, J., Freund, M., Hanauske, A., Heil, G., Kaufmann, C., Kem, W., Schlussler, M., Hiddemann, W. and Scleyer, E. (1998) "Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma-phase I/II studies and pharmacokinetics", Leukemia 12, 11618-11626.
Multiple Complete Remissions in a Patient with Acute Myeloid Leukemia (M4eo) with Low-dose Cytosine Arabinoside and All- trans Retinoic Acid
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.